Anti-COVID nasal spray to be available from October 1st

ChulaCov19 COVID-19 vaccine VRC testing

ChulaCov19 COVID-19 vaccine VRC testing. Photo: Chulalongkorn University.

An anti-COVID nasal spray, an innovation jointly developed by Health Systems Research Institute (HSRI), the Faculty of Medicine at Chulalongkorn University, the Government Pharmaceutical Organization (GPO) and Hibiocy Company, will be commercially available from October 1st.

Dr. Nopporn Cheanklin, director of the PHRI, said today (Tuesday) that the Anti-COVID nasal spray, trade-name “Vaill CoviTRAP”, has already been approved by the Thai Food and Drug Administration.

Full story:

By Thai PBS World

Facebook Notice for EU! You need to login to view and post FB Comments!

Leave a Reply